Back

Title
  • Transcriptional regulation of the legumain gene by p53 in HCT116 cells
Creator

Yamane, Takuya

Murao, Sato

Kato-Ose, Izumi

Kashima, Lisa

NRID 1000030404750

Yuguchi, Motoki

Kozuka, Miyuki

Takeuchi, Keisuke

NRID 1000040432306

Ogita, Hisakazu

NRID 1000050379236

Ohkubo, Iwao

NRID 1000080152073

Ariga, Hiroyoshi

NRID 1000020143505
Subject
  • Other Legumain
  • Other p53
  • Other Doxorubicin
  • NDC 499
Description
Other
  • Legumain (EC 3.4.22.34) is an asparaginyl endopeptidase. Strong legumain activity was observed in the mouse kidney, and legumain was found to be highly expressed in tumors. We previously reported that bovine kidney annexin A2 was co-purified with legumain and that legumain cleaved the N-terminal region of annexin A2 at an Asn residue in vitro and in vivo. In this study, we found a p53-binding site in intron 1 of the human legumain gene using computational analysis. To determine whether transcription of the legumain gene is regulated by p53, HCT116 cells were transfected with p53 siRNA and the effect of knockdown of p53 expression on legumain expression was examined. The results showed that expression levels of both legumain mRNA and protein were decreased in the siRNA-treated cells. Furthermore, enzyme activity of legumain was also increased by doxorubicin and its activity was reduced by knockdown of p53 in HCT116 cells. These results suggest that legumain expression and its enzyme activity are regulated by p53. (C) 2013 Elsevier Inc. All rights reserved.
PublisherAcademic press inc elsevier science
Date Issued 2013-09-06
Languageeng
NIItypejournal article
VersiontypeAM
Identifier URI http://hdl.handle.net/2115/54547
Relation
  • isIdenticalTo PMID 23942113
  • isIdenticalTo DOI https://doi.org/10.1016/j.bbrc.2013.08.007
Journal
    • ISSN 0006-291X
    • Biochemical and biophysical research communications
    438(4), 613-618
File
Oaidate2019-03-15T05:20:38Z